Stocks
G1 Therapeutics (GTHX) EBITDA margin US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -210.9% | -452.6% | -263.0% | -41.6% | -57.6% | |||
| Changes by years, y/y, % | -242pp | +190pp | +221pp | -41.8% | |||||
G1 Therapeutics. EBITDA margin, %
G1 Therapeutics. EBITDA margin, changes, pp
G1 Therapeutics (GTHX) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | 30.3% | -122.4% | -52.0% | -56.1% | -15.8% | -57.6% | |
| Changes by years, y/y, % | +379pp | -33pp | +241pp | +132pp | -46pp | |||
| Changes by quarters, q/q, % | +219pp | -153pp | +70pp | -4pp | +40pp | |||
